Search details
1.
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
J Neuroinflammation
; 14(1): 164, 2017 Aug 18.
Article
in English
| MEDLINE | ID: mdl-28821274
2.
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Mov Disord
; 31(6): 924-32, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27113479
3.
The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.
Mov Disord
; 34(5): 676-681, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30901492
4.
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Lancet Neurol
; 23(2): 178-190, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38267190
5.
Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) has InsP(3)-independent gating and disrupts intracellular Ca(2+) homeostasis.
J Biol Chem
; 286(41): 35998-36010, 2011 Oct 14.
Article
in English
| MEDLINE | ID: mdl-21859719
6.
Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons.
J Neurochem
; 123(1): 147-58, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22762283
7.
Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease.
Mov Disord Clin Pract
; 9(1): 76-81, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-35005068
8.
Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest.
Crit Care Med
; 39(6): 1423-30, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21610611
9.
Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as Mud.
Neurol Clin Pract
; 11(4): e462-e471, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34476127
10.
Triggers and alleviating factors for fatigue in Parkinson's disease.
PLoS One
; 16(2): e0245285, 2021.
Article
in English
| MEDLINE | ID: mdl-33540422
11.
The Experience of OFF Periods in Parkinson's Disease: Descriptions, Triggers, and Alleviating Factors.
J Patient Cent Res Rev
; 8(3): 232-238, 2021.
Article
in English
| MEDLINE | ID: mdl-34322575
12.
Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis.
Front Neurol
; 12: 633645, 2021.
Article
in English
| MEDLINE | ID: mdl-33597918
13.
Genetic Testing for Parkinson Disease: Are We Ready?
Neurol Clin Pract
; 11(1): 69-77, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33968475
14.
The experience of care partners of patients with Parkinson's disease psychosis.
PLoS One
; 16(3): e0248968, 2021.
Article
in English
| MEDLINE | ID: mdl-33740031
15.
Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).
Ann Clin Transl Neurol
; 8(2): 308-320, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33350601
16.
The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease.
Mov Disord Clin Pract
; 7(3): 284-292, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32258226
17.
Current and projected future economic burden of Parkinson's disease in the U.S.
NPJ Parkinsons Dis
; 6: 15, 2020.
Article
in English
| MEDLINE | ID: mdl-32665974
18.
Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease.
Sci Data
; 7(1): 67, 2020 02 24.
Article
in English
| MEDLINE | ID: mdl-32094335
19.
Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants.
Neurol Clin Pract
; 10(1): 7-14, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-32190415
20.
Understanding the Lexicon of Fatigue in Parkinson's Disease.
J Parkinsons Dis
; 10(3): 1185-1193, 2020.
Article
in English
| MEDLINE | ID: mdl-32568110